Compare
Peptide comparison guides
When two peptides cover overlapping endpoints, the right choice for a research protocol depends on mechanism, route, evidence base, and tolerability.
Semax vs Selank
Head-to-head comparison of Semax and Selank: mechanism, target endpoints, evidence base, dosing routes, and the case for combining them in research.
CompareDihexa vs Cerebrolysin
Comparison of Dihexa (single synaptogenic hexapeptide) and Cerebrolysin (multi-component porcine brain preparation) for cognitive and neuroprotective research.
CompareNoopept vs Semax
Compare Noopept and Semax — two Russian cognitive enhancers with overlapping endpoints but very different chemistry, routes, and pharmacokinetic profiles.
ComparePeptides vs Racetams
Head-to-head comparison of the research-peptide family (Semax, Selank, Noopept, Dihexa) and the racetam family (piracetam, aniracetam, oxiracetam) — mechanism, evidence, delivery route, regulatory status.
CompareBPC-157 vs TB-500
Head-to-head comparison of BPC-157 (Body Protection Compound 157, gastric-juice-derived) and TB-500 (Thymosin β4 fragment) — the two most-referenced tissue-repair research peptides with adjacent cognitive-relevance research angles.
CompareCerebrolysin vs Cortexin
Head-to-head comparison of Cerebrolysin (porcine-brain peptide preparation, Austrian origin) and Cortexin (bovine-cortex peptide preparation, Russian origin). Sources, routes, indications, evidence base, and selection criteria.
CompareCerebrolysin vs Epitalon
Head-to-head comparison of Cerebrolysin (porcine-brain multi-component peptide preparation, substantial international clinical evidence) and Epitalon (Khavinson pineal tetrapeptide bioregulator with extended human follow-up data).
CompareDihexa vs FGL Peptide
Head-to-head comparison of Dihexa (HGF/c-Met synaptogenic hexapeptide) and FGL Peptide (NCAM/FGFR1 synaptogenic 15-mer). Mechanisms, oral vs parenteral bioavailability, evidence base, and research applications.
CompareDihexa vs GHK-Cu
Head-to-head comparison of Dihexa (HGF/c-Met synaptogenesis mechanism) and GHK-Cu (endogenous copper-binding tripeptide with broad gene-expression modulation). Different mechanism-of-action angles for different cognitive-relevance research applications.
CompareDihexa vs P21
Head-to-head comparison of Dihexa (HGF/c-Met synaptogenesis) and P21 (CNTF-derived hippocampal neurogenesis). New synapses vs new neurons — different cognitive-plasticity mechanisms for different research designs.
CompareEpitalon vs DSIP
Head-to-head comparison of Epitalon (Khavinson pineal-targeting tetrapeptide) and DSIP (delta sleep-inducing peptide). Both influence sleep architecture but through different upstream mechanisms — pineal vs HPA axis vs thalamocortical.
CompareFGL Peptide vs P21
Head-to-head comparison of FGL peptide (NCAM-derived FGFR agonist with Alzheimer's Phase II history) and P21 (CNTF-derived neurogenic hexapeptide). Two distinct receptor-signalling angles for cognitive-plasticity research.
CompareIpamorelin vs CJC-1295
Head-to-head comparison of Ipamorelin (selective ghrelin receptor agonist / GHRP) and CJC-1295 (long-acting GHRH analogue). The classical GH-axis research-tool stack pair — different receptor engagement, mechanistically synergistic.
CompareN-Acetyl Semax vs Cycloprolylglycine
Head-to-head comparison of N-Acetyl Semax (long-acting acetylated Semax analogue) and Cycloprolylglycine (endogenous cyclic dipeptide as Noopept's active metabolite). Two distinct Russian cognitive-peptide research tools.
CompareNoopept vs Cycloprolylglycine
Noopept is rapidly hydrolysed in vivo to cycloprolylglycine (CPG). Head-to-head comparison of the parent peptidomimetic and its endogenous active metabolite — pharmacokinetics, mechanism, and research-tool positioning.
CompareNoopept vs N-Acetyl Semax
Head-to-head comparison of Noopept (racetam-family cognitive support with CPG as active metabolite) and N-Acetyl Semax (extended-duration acetylated Semax analogue with enhanced pharmacokinetics).
ComparePinealon vs Cerebrolysin
Head-to-head comparison of Pinealon (Glu-Asp-Arg Khavinson short-peptide bioregulator, preclinical evidence base) and Cerebrolysin (porcine-brain multi-component peptide preparation with substantial international clinical evidence).
ComparePinealon vs Cortexin
Head-to-head comparison of Pinealon (defined tripeptide bioregulator with preclinical evidence) and Cortexin (bovine-cortex-derived multi-component polypeptide preparation with substantial Russian paediatric neurological licensed use).
ComparePinealon vs Epitalon
Head-to-head comparison of Pinealon (Glu-Asp-Arg tripeptide) and Epitalon (Ala-Glu-Asp-Gly tetrapeptide) — the two flagship Khavinson-school bioregulators on this site. Mechanism, target endpoints, and how they complement each other in research.
CompareSelank vs N-Acetyl Selank Amidate
Head-to-head comparison of Selank (the parent tuftsin analogue) and N-Acetyl Selank Amidate (its protected extended-half-life analogue). Anxiolytic pharmacology, dosing frequency, evidence base, and selection criteria.
CompareSelank vs Oxytocin
Head-to-head comparison of Selank (Russian tuftsin-analogue anxiolytic with clinical trial evidence) and Oxytocin (endogenous nonapeptide with social-cognition research applications). Different mechanisms for adjacent research-tool positioning in anxiety and social behaviour.
CompareSemaglutide vs Liraglutide
Head-to-head comparison of Semaglutide (once-weekly injectable GLP-1 receptor agonist, EVOKE Alzheimer Phase III, no slowing of progression) and Liraglutide (once-daily injectable GLP-1 receptor agonist, ELAD Alzheimer Phase II). Both licensed for metabolic indications with growing cognitive-relevance research.
CompareSemax vs Cycloprolylglycine
Head-to-head comparison of Semax (ACTH(4-10) analogue with substantial clinical evidence base) and Cycloprolylglycine (the endogenous dipeptide that emerges as Noopept's active metabolite). Two Russian-programme cognitive research compounds with distinct mechanism-of-action framing.
CompareSemax vs N-Acetyl Semax Amidate
Head-to-head comparison of Semax (the parent ACTH(4-10) analogue) and N-Acetyl Semax Amidate (its extended-half-life protected analogue). Pharmacokinetics, dosing, evidence base, and when to choose which.
Compare